Search

everythinglearnresearchcommunity

for

Search:↓

Early hair loss may indicate future prostate issues.

Micrografts and minigrafts for hair restoration provide high patient satisfaction and can cover large areas of hair loss, including sideburns, eyebrows, and beards.

Granules improve hair loss treatment by targeting follicles.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

Fermented red ginseng and a traditional herb mix improved hair growth in mice.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

PRGF treatments increased hair number and thickness in people with hair loss, with more injections leading to better results.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Caraway, Chinese chives, and cassia may improve health and prevent diseases due to their nutrients and medicinal properties.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Finasteride and dutasteride may help prevent hair loss but could cause side effects like sexual dysfunction and psychological issues.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Nearly half of the classification tools in the National Institute of Health and Clinical Excellence's Clinical Knowledge Summaries might not effectively guide management for general practitioners.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Treatments for hair loss vary, but cell-based options may be the future.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Male pattern baldness involves genetics, hormones, and needs better treatments.